Toronto Stocks Slide Along With U.S. Markets; Canopy Growth Tumbles as 4Q Misses Views
By Adriano Marchese
Toronto stocks were down mid-trading on Friday in lockstep with U.S. markets, and with the S&P/TSX Composite Index on track for a 2% weekly decline. Only Canada's consumer durables and communications sectors were posting gains, while tech was the outsized laggard, followed by process industries and producer manufacturing.
Canada's S&P/TSX Composite Index slid 0.68% to 19448.41 while the blue-chip S&P/TSX 60 fell by 0.62% to 1172.15.
Shares of Canopy Growth were over 10% lower at 69 Canadian cents (52 cents) after the cannabis company reported a wider loss and a decline in revenue in its fiscal fourth quarter late Thursday. Loss widened to C$640.1 million, or C$1.28 a share, for the three months ended March 31, from a loss of C$582.5 million, or C$1.48 Canadian a share, a year earlier. Analysts polled by FactSet expected a loss of 21 Canadian cents a share. Revenue declined to C$87.5 million from C$101.8 million.
Other market movers:
Stillwater Critical Minerals's shares jumped 21% to C$0.20 after the minerals explorer struck a deal to sell an almost 10% stake of the company for C$4.9 million to Swiss mining and trading giant Glencore.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
June 23, 2023 12:22 ET (16:22 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom